Evidence map›Paper›PMID 24516449›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2013

Prevalence and antibiotic susceptibility of Bacteroides fragilis group isolated from stool samples in North Lebanon.

Mariam Yehya, Monzer Hamze, Hassan Mallat, Fouad Dabbousi

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Phase variation inEngineering microbiology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Bloodstream infection caused byThe Journal of international medical research · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mariam YehyaHealth and Environmental Microbiology Laboratory, AZM Centre for Research in Biotechnology and its Application, Doctoral School, Lebanese University, Tripoli, Lebanon.
Monzer HamzeHealth and Environmental Microbiology Laboratory, AZM Centre for Research in Biotechnology and its Application, Doctoral School, Lebanese University, Tripoli, Lebanon. ; Faculty of Public Health, Section 3, Lebanese University, Tripoli, Lebanon.
Hassan MallatHealth and Environmental Microbiology Laboratory, AZM Centre for Research in Biotechnology and its Application, Doctoral School, Lebanese University, Tripoli, Lebanon. ; Faculty of Public Health, Section 3, Lebanese University, Tripoli, Lebanon.
Fouad DabbousiHealth and Environmental Microbiology Laboratory, AZM Centre for Research in Biotechnology and its Application, Doctoral School, Lebanese University, Tripoli, Lebanon. ; Faculty of Public Health, Section 3, Lebanese University, Tripoli, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fifty one strains of the Bacteroides fragilis group were isolated from 45 fecal samples. Classical phenotypic identification showed that 16 isolates were B. thetaiotaomicron, 12 B. uniformis, 9 B. eggerthii, 7 B. vulgatus, 3 B. caccae, 2 Parabacteroides distasonis with 1 identified B. ovatus and 1 B. fragilis. The 51 strains were tested for susceptibility against 16 antimicrobial agents and the MICs for metronidazole were determined. The tests showed that imipenem, meropenem and chloramphenicol were the most effective antibiotics (98%, 98% and 92.16% of susceptibility, respectively) followed by ticarcillin/clavulanic acid, piperacillin/tazobactam, rifampin (88.24% susceptibility), moxifloxacin 86.27% and tigecycline 84.31%. Ofloxacin and cefotaxime were the least effective antibiotics with 27.45% and 0% of activity respectively. Only six of the 51 isolated strains were resistant to metronidazole with MICs = 64 mg/L (1 strain) and > 256 mg/L (5 strains).

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsBacteroides fragilisChildChild, PreschoolDrug Resistance, BacterialFecesFemaleHumansInfantInfant, NewbornLebanonMaleAnti-Bacterial Agentsanaerobic bacteriaantibiotics susceptibilityBacteroides fragilis group

Identifiers

PMID24516449
PMCPMC3910193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.